“…Many observational, cross-sectional and clinical studies reported that patients with MG may suffer from excessive daytime sleepiness [6,9,11,12,45], reduced sleep and awakening quality, reduced sleep efficiency, reduced REM-sleep, increased number of nocturnal awakenings, microarousals, poor sleep quality index scores [13], morning drowsiness, headaches [11,13], altered sleep perception and dreaming, increased dream recall frequency, increased tactile sensations during dreaming and dreamed less often visually [11] and restless leg syndrome (RLS) [14]. Excessive daytime sleepiness was reported in 25% (21/84) [9] and 31.5% (6/19) [12] of patients with MG. Studies reported no relationship between stable MG and excessive daytime sleepiness [6,9,12] and lack of effect of plasmapheresis treatment on polysomnographic abnormalities despite improved clinical weakness and decreased MG score and AChR Abs concentration [46].…”